Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:May 10, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:May 10, 2017Unknown status
Condition(s):IIIB/IIIC/IV Lung CancerLast Updated:June 14, 2019Unknown status
Condition(s):Stomach CancerLast Updated:December 19, 2023Recruiting
Condition(s):HER2-positive Early Breast CancerLast Updated:December 27, 2023Completed
Condition(s):Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction AdenocarcinomaLast Updated:May 17, 2021Recruiting
Condition(s):Advanced Endometrial Cancer; Sarcoma of UterusLast Updated:July 24, 2023Recruiting
Condition(s):Breast CancerLast Updated:November 16, 2020Unknown status
Condition(s):Breast Cancer; Pathological Complete Response; Neoadjuvant ChemotherapyLast Updated:November 21, 2017Unknown status
Condition(s):Non-small-cell Lung CancerLast Updated:November 21, 2023Recruiting
Condition(s):HER2-positive Breast CancerLast Updated:February 9, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.